Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ampicillin-specific rashes

B B Adcock1, D P Rodman

  • 1Department of Family Medicine, University of Alabama School of Medicine at Tuscaloosa, USA.

Archives of Family Medicine
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermographism: an adverse effect of atorvastatin.

The Journal of the American Board of Family Practice·2001
Same author

Evaluation of primary care residents' knowledge of pharmacotherapy.

Southern medical journal·1999
Same author

Facial numbness: a manifestation of sarcoidosis.

The Journal of the American Board of Family Practice·1999
Same author

The need for comprehensive pharmacotherapy curricula.

Academic medicine : journal of the Association of American Medical Colleges·1998
Same author

Low-molecular-weight heparins in coronary arterial thrombus disease: a review of the literature.

Pharmacotherapy·1998
Same author

Paresthesias: a practical diagnostic approach.

American family physician·1997
Same journal

Living in medicine: med school after 50 years plus 2 weeks

Archives of family medicine·2000
Same journal

Phytophotodermatitis: a sometimes difficult diagnosis.

Archives of family medicine·2000
Same journal

Case description of ascariasis.

Archives of family medicine·2000
Same journal

Microscopic polyangiitis in a pediatric patient.

Archives of family medicine·2000
Same journal

Advance care planning.

Archives of family medicine·2000
Same journal

Gaps in end-of-life care.

Archives of family medicine·2000
See all related articles

Ampicillin rashes occur in 3-8% of patients. Differentiating non-hypersensitivity rashes from true allergic reactions is crucial for continued ampicillin use.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Immunology

Background:

  • Ampicillin frequently causes skin rashes, affecting 3% to 8% of individuals.
  • Distinguishing ampicillin-induced rashes is critical for patient management and antibiotic therapy.
  • "Ampicillin-specific" rashes are non-hypersensitivity reactions, while true hypersensitivity reactions present with urticarial and anaphylactic features.

Purpose of the Study:

  • To review the characteristics of ampicillin-induced rashes.
  • To highlight the clinical implications of differentiating non-hypersensitivity from hypersensitivity reactions.
  • To underscore the challenge in definitively distinguishing between these two types of ampicillin rashes.

Main Methods:

  • Review of existing literature on ampicillin-induced dermatological reactions.

Related Experiment Videos

  • Analysis of clinical presentations differentiating non-hypersensitivity and hypersensitivity ampicillin rashes.
  • Discussion of management strategies based on rash characteristics.

    • Main Results:

    • Ampicillin-specific rashes manifest as maculopapular erythema with minimal pruritus or irritation.
    • True hypersensitivity reactions involve urticaria and potential anaphylaxis, necessitating drug cessation.
    • Current scientific methods lack the immediacy to definitively differentiate between these rash types.

    Conclusions:

    • Prompt identification of ampicillin hypersensitivity is vital for patient safety.
    • Non-hypersensitivity ampicillin rashes may permit continued antibiotic therapy and future beta-lactam use.
    • Further research is needed to develop definitive diagnostic tools for ampicillin-induced rashes.